Iodide

Iodide

SCHEMBL3859955

CCCCCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[I-]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.56
CHRNA7 P36544 9/20 0.49
TRAP1 Q12931 2/20 0.46
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
TSHR P16473 1/20 0.44
CYP2C19 P33261 1/20 0.44
CSNK1E P49674 1/20 0.41
DNM1 Q05193 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL298493 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2
Iodide SCHEMBL5085194 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2
Iodide SCHEMBL2505241 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2
Iodide SCHEMBL10684637 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2
Iodide SCHEMBL6904643 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2
Decyltriphenylphosphonium SCHEMBL3654788 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2
Iodide SCHEMBL5085133 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2
Iodide SCHEMBL2354963 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2
Iodide SCHEMBL5091833 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2
Iodide SCHEMBL5086696 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9238606-B1 Methyl-Iodide-free carbonylation of methanol to acetaldehyde EASTMAN CHEMICAL COMPANY (US) 2016-01-19 US claimed
US-9718754-B2 Methyl-iodide-free carbonylation of an alcohol to its homologous aldehyde and/or alcohol EASTMAN CHEMICAL COMPANY (US) 2017-08-01 US disclosed
US-9714206-B2 Methyl-iodide-free carbonylation of an alcohol to its homologous aldehyde and/or alcohol EASTMAN CHEMICAL COMPANY (US) 2017-07-25 US disclosed
US-20160251292-A1 METHYL-IODIDE-FREE CARBONYLATION OF AN ALCOHOL TO ITS HOMOLOGOUS ALDEHYDE AND/OR ALCOHOL EASTMAN CHEMICAL COMPANY (US) 2016-09-01 US disclosed
US-20160185701-A1 METHYL-IODIDE-FREE CARBONYLATION OF AN ALCOHOL TO ITS HOMOLOGOUS ALDEHYDE AND/OR ALCOHOL EASTMAN CHEMICAL COMPANY (US) 2016-06-30 US disclosed
US-20160185700-A1 METHYL-IODIDE-FREE CARBONYLATION OF AN ALCOHOL TO ITS HOMOLOGOUS ALDEHYDE AND/OR ALCOHOL EASTMAN CHEMICAL COMPANY (US) 2016-06-30 US disclosed
US-9365479-B1 Methyl-iodide-free carbonylation of an alcohol to its homologous aldehyde and/or alcohol EASTMAN CHEMICAL COMPANY (US) 2016-06-14 US disclosed
US-9266807-B1 Conversion of alcohols to longer chain aldehydes or alcohols EASTMAN CHEMICAL COMPANY (US) 2016-02-23 US disclosed
US-9238606-B1 Methyl-Iodide-free carbonylation of methanol to acetaldehyde EASTMAN CHEMICAL COMPANY (US) 2016-01-19 US disclosed
US-20130199599-A1 POLYESTER FILM, BACK SHEET FOR SOLAR CELL, AND SOLAR CELL MODULE FUJIFILM CORPORATION (JP) 2013-08-08 US disclosed
EP-0518973-B1 ISOMERIZATION OF EPOXYALKENES TO 2,5-DIHYDROFURANS AND CATALYSTS COMPOSITIONS USEFUL THEREFOR EASTMAN CHEM CO (US) 1995-01-11 EP disclosed
EP-0624157-A1 CONTINUOUS PROCESS FOR THE MANUFACTURE OF 2,5-DIHYDROFURANS FROM -g(g),-g(d)-EPOXYBUTENES. EASTMAN CHEM CO (US) 1994-11-17 EP disclosed
US-5315019-A Continuous process for the manufacture of 2,5-dihydrofurans from γ, δ-epoxybutenes EASTMAN CHEMICAL COMPANY (US) 1994-05-24 US disclosed
WO-1993010111-A1 CONTINUOUS PROCESS FOR THE MANUFACTURE OF 2,5-DIHYDROFURANS FROM η,δ-EPOXYBUTENES EASTMAN KODAK COMPANY (US) 1993-05-27 WO disclosed
EP-0518973-A1 ISOMERIZATION OF EPOXYALKENES TO 2,5-DIHYDROFURANS AND CATALYSTS COMPOSITIONS USEFUL THEREFOR. EASTMAN KODAK CO (US) 1992-12-23 EP disclosed
US-5082956-A Quaternary onium iodide catalyst EASTMAN KODAK COMPANY (US) 1992-01-21 US disclosed
WO-1991013882-A1 ISOMERIZATION OF EPOXYALKENES TO 2,5-DIHYDROFURANS AND CATALYSTS COMPOSITIONS USEFUL THEREFOR EASTMAN KODAK COMPANY (US) 1991-09-19 WO disclosed
US-4568494-A Process for the preparation of TCNQ complexes BAYER AKTIENGESELLSCHAFT (DE) 1986-02-04 US disclosed
EP-0138093-A2 Process for the preparation of TCNQ complexes BAYER AG (DE) 1985-04-24 EP disclosed
US-4052427-A PROCESS FOR THE PREPARATION OF DIALKYLTIN DIHALIDES WITCO CHEMICAL CORPORATION (US) 1977-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160185701-A1 METHYL-IODIDE-FREE CARBONYLATION OF AN ALCOHOL TO ITS HOMOLOGOUS ALDEHYDE AND/OR ALCOHOL ADH1C, ADH5, ADH1A HIF1A 3511/4885CHRNA7 690/4885TRAP1 622/4885
US-20160251292-A1 METHYL-IODIDE-FREE CARBONYLATION OF AN ALCOHOL TO ITS HOMOLOGOUS ALDEHYDE AND/OR ALCOHOL ADH1C, ADH5, ADH1A HIF1A 2608/4885CHRNA7 691/4885TRAP1 750/4885
US-20160185700-A1 METHYL-IODIDE-FREE CARBONYLATION OF AN ALCOHOL TO ITS HOMOLOGOUS ALDEHYDE AND/OR ALCOHOL ADH1C, ADH5, ADH1A HIF1A 2608/4885CHRNA7 691/4885TRAP1 750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.